Korea Joongang Daily
Korea JoongAng Daily

Samsung Biologics acquires three ISO certificates, including for compliance management

Samsung Biologics said on Friday that it was granted three certifications from the International Organization for Standardization (ISO), including for compliance management and information security.

2024-11-08

Samsung Biologics signs largest-ever $1.2 billion deal

Samsung Biologics has signed its largest contract ever, worth $1.2 billion, with an unnamed Asian company, aiming to expand its manufacturing capacity to meet increasing global bio market demand.

2024-10-22

Samsung Biologics sets sights on Japan as new market of opportunity

YOKOHAMA, Japan — Samsung Biologics has set its eyes on Japan, the world’s third-largest pharmaceutical market, as it looks for new room for growth beyond the United States and Europe.

2024-10-10

CEO of Japan's largest biotech cluster touts growing opportunities for Korean startups

“However, with the recent improvements in the relationship between Japan and Korea, a new route into the U.S. through the Asian market has emerged,” said Fujimoto.

2024-10-09

Biotech and pharmaceutical stocks bullish on U.S. rate cut

Samsung Biologics continued its record-setting streak on Monday to close at 1,087,000 won as other biotech and pharmaceutical shares also soared.

2024-09-23

Court sides with Samsung Biologics over accounting fraud

The Seoul Administrative Court on Wednesday ruled in favor of Samsung Biologics for alleged accounting fraud, canceling a fine imposed on the Korean biotech company by the Financial Services Commission (FSC).

2024-08-14

Samsung Biologics' net profit jumps 72 percent in Q2

Samsung Biologics, the biotech arm of Korea's Samsung Group, said Wednesday its second-quarter net profit jumped 72 percent from a year earlier on robust sales.

2024-07-24

Samsung Biologics to tout upcoming ADC plant at biotech expo

Samsung Biologics will attempt to lure clients with its soon-to-open plant for antibody-drug conjugates, a promising next-generation cancer treatment, at BioPlus Interphex Korea 2024.

2024-07-09

Samsung Biologics bags company record $1.06B deal with U.S. drug maker

Samsung Biologics has secured a $1.06 billion contract with an unnamed U.S. drug maker, its largest ever.

2024-07-02

Samsung Biologics introduces corporate culture vision

The biopharmaceutical contract manufacturer said that its new corporate culture vision, emphasizing respect and transparency, is good for employees and the company.

2024-06-20